U.S. Opioids Market

Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids such as fentanyl, and various pain relievers prescribed legally, such as oxycodone, hydrocodone, and others. This class of drug is primarily taken for pain relief. It has been used for other medical purposes including cough and diarrhea treatment. They bind to opioids receptor and produce a desirable result. In recent years, there has been an increase in the use of prescription opioids for the treatment of chronic, non-cancer pain, such as back pain or osteoarthritis, despite serious risks and the lack of evidence about their long-term effectiveness. Opioids are generally safe when taken for a short time, regular use of the drug can lead to dependence and in extreme cases may even result in death. Opioids are addicting because they not only relieve pain but also generate euphoria. This, combined with the development of tolerance (the need to raise dosages to achieve the same effect), can result in opioid use disorder. As a result, prescribers have changed their methods to minimize the length and potency of opioids in an attempt to prevent addiction.

Market Dynamics

The increasing rate of unemployment is expected to drive the market growth, owing to the increased opioids misuse. For instance, according to an article published by AzoNetwork, an online publisher, in May 2022, two studies led by the National Survey of Drug Use and Health (NSDUH), and the national population-based Midlife in the U.S. (MIDUS) Study found that strong associations between drug misuse generally and opioid misuse specifically among unemployed Americans, who were found to have a 40% higher likelihood to misuse opioids than those working 35-40 hours per week.

Key features of the study:

• This report provides an in-depth analysis of the U.S. opioids market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  country outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. opioids market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Purdue Pharmaceuticals L.P., Titan Pharmaceuticals, Inc., Pfizer Inc., Mallinckrodt, Pfizer Inc., Assertio Holdings, Inc., Par Pharmaceutical, Amneal Pharmaceuticals LLC, Trevena, Inc., Lupin, and Endo Pharmaceuticals, Inc. 
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. opioids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. opioids market

Detailed Segmentation:

• U.S. Opioids Market, By Drugs:
  • Codeine
  • Fentanyl 
  • Meperidine 
  • Methadone 
  • Morphine 
  • Hydrocodone
• U.S. Opioids Market, By Therapeutic Application:
  • Pain Management
    • Neuropathic Pain
    • Migraine
    • Back Pain
    • Osteoarthritis Pain
    • Cancer Pain
    • Others
  • Cough Treatment
  • Diarrhea Treatment
• U.S. Opioids Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Company Profiles
• • Purdue Pharmaceuticals L.P.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Titan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Mallinckrodt
  • Pfizer Inc.
  • Assertio Holdings, Inc.
  • Par Pharmaceutical
  • Amneal Pharmaceuticals LLC
  • Trevena, Inc.
  • Lupin
  • Endo Pharmaceuticals, Inc.  

 “*” marked represents similar segmentation in other categories in the respective section.